Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes

Back

ESC Professional Premium Access

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes

Session: Myocardial ischaemia and heart failure: insight from multimodality imaging

Topic: Imaging of Heart Failure

Speaker: Mr M. Alghamdi (Dundee, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Mohmmad Alghamdi

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

The role of semi-quantitative parameters of thallium-201 myocardial perfusion imaging in predicting mortality rate among CKD population

Speaker: Doctor Y. Liu (Kaohsiung, TW)

Rosuvastatin effect on atherosclerotic plaque microcalcification

Speaker: Doctor M. Santos (Coimbra, PT)

Predictors of LV reverse remodeling after SAVR: insights from a prospective TTE and CMR study in patients with severe aortic stenosis.

Speaker: Doctor R. Reis Santos (Lisbon, PT)

The correlation between cardiac magnetic resonance imaging and echocardiography in patients with severe ischaemic cardiomyopathy

Speaker: Doctor T. Aklilu (London, GB)

Trend in culprit plaque phenotype in ACS patients over the past 10 years

Speaker: Doctor K. Suzuki (Boston, US)

Access the full session

Myocardial ischaemia and heart failure: insight from multimodality imaging

Speakers: Mr M. Alghamdi, Doctor Y. Liu, Doctor M. Santos, Doctor R. Reis Santos, Doctor T. Aklilu...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources